Growth factors in haematology: prophylactic versus interventional use.
Boogaerts
M A
MA
Department of Hematology, University Hospital, Leuven, Belgium.
D000970:Antineoplastic Agents / Q000009:adverse effects; D016026:Bone Marrow Transplantation; D016298:Hematopoietic Cell Growth Factors / Q000009:adverse effects / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007938:Leukemia / Q000628:therapy; D008223:Lymphoma / Q000188:drug therapy; D009190:Myelodysplastic Syndromes / Q000628:therapy; D009503:Neutropenia / Q000517:prevention & control
D000970:Antineoplastic Agents; D016298:Hematopoietic Cell Growth Factors